Galectins: From Human Lectin to Therapeutic Target For Many Of Today's Diseases
Super Human Radio
Type 2 Diabetes
There's carbohydrate based drugs that what they do is they block the interaction with these collectins. You see the collectins going back to my collecting challenge in the beginning. Collectins are the ones that are responsible for all these chronic diseases. What you want to do is you want to basically silence them. So what you need is a galectin antagonist. The carbohydrate is is the galectin antagonists. It doesn't recognize other proteins. Right, it only recognizes these. Like glucomatine. Yeah, so a specific carbohydrate is what this lectin recognizes. And we live in a space today where carbohydrates is a bad word. Because of type two diabetes and now you're
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
